Skip to content
ppharmaranks
Menu

ADCIRCA vs ALYQ

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Rating

70/100
56/100

Pharmacy pays

~$4.43 /30
~$4.43 /30

Type

RX
RX

Active ingredient

TADALAFIL
TADALAFIL

Manufacturer

Dosage forms

Tablet
Tablet

Drug class

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitor

Boxed warning

None
None

Half-life

about 17.5 hours
about 17.5 hours

Treats

Pulmonary Hypertension, Vasculogenic Impotence
Pulmonary Hypertension, Vasculogenic Impotence

Get adcircahigher-rated option

Advertising disclosure: Some links are affiliate links. We may earn a commission at no extra cost to you. This never affects our independent ratings.

Get treatment online

Licensed online providers — consult & get prescribed if eligible.

Frequently asked questions

Which is better-rated, Adcirca or Alyq?

By our independent rating, Adcirca scores higher — 3.5 vs 2.8 out of 5 for Alyq. Ratings are based on FDA regulatory (recall-safety) data.

Which is cheaper, Adcirca or Alyq?

Pharmacies pay about the same to acquire either one — roughly $4.43 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Adcirca and Alyq?

Both Adcirca and Alyq share the active ingredient Tadalafil.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.